NASDAQ:DARE | Free Cash Flow | Dare Bioscience, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$5.52M$0.00-$5.52M
2025-12-31$1.44M$206,641.00$1.24M
2025-03-31-$5.47M$157,331.00-$5.63M
2024-12-31$5.31M$562,849.00$4.74M
2024-03-31-$6.81M$7,296.00-$6.82M
2023-12-31-$8.18M$607,331.00-$8.79M
2023-03-31-$16.12M$0.00-$16.12M
2022-12-31-$5.9M$2,697.00-$5.9M
2022-03-31-$12.34M$4,553.00-$12.35M
2021-12-31-$9.92M$0.00-$9.92M
2021-03-31-$8.38M$0.00-$8.38M
2020-12-31-$9.19M$2,379.00-$9.2M
2020-03-31-$6.6M
2019-12-31-$3.81M$0.00-$3.81M
2019-03-31-$3.31M
2018-12-31-$2.71M$0.00-$2.71M
2018-03-31-$2.12M
2017-12-31-$961,068.00
2017-03-31-$50,595.00
2016-12-31-$166,952.00$36,000.00-$202,952.00
2016-03-31-$13.26M$359,000.00-$13.62M
2015-12-31-$8.21M$136,000.00-$8.35M
2015-03-31-$7.94M$29,000.00-$7.97M
2014-12-31-$5.61M$109,000.00-$5.72M
2014-03-31-$3.67M$14,000.00-$3.68M
2013-12-31-$3.27M$0.00-$3.27M
2013-03-31-$4.6M$2,000.00-$4.6M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$9.89M$385,278.00-$10.27M
2024-12-31$5.47M$573,046.00$4.9M
2023-12-31-$38.86M$629,430.00-$39.49M
2022-12-31-$18.09M$63,069.00-$18.15M
2021-12-31-$28.76M$14,524.00-$28.78M
2020-12-31-$25.23M$17,625.00-$25.25M
2019-12-31-$13.32M$0.00-$13.32M
2018-12-31-$10.27M$11,836.00-$10.28M
2017-12-31-$2.54M$0.00-$2.54M
2016-12-31-$372,299.00$535,000.00-$907,299.00
2015-12-31-$31.92M$277,000.00-$32.19M
2014-12-31-$19.06M$225,000.00-$19.29M
2013-12-31-$16.61M$7,000.00-$16.62M
2012-12-31-$21.01M$180,000.00-$21.19M